Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Tax Provisions across 17 years of filings, most recently posting $3871.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $3871.0, down 31.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $38201.0 (up 234.32% YoY), and the FY2025 annual result was $40000.0, up 276.45% from the prior year.
• Tax Provisions came in at $3871.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $22989.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $48150.0 in Q4 2022 to a low of -$56996.0 in Q4 2024.
• The 5-year median for Tax Provisions is $6937.0 (2023), against an average of $7989.5.
• Across the five-year window, Tax Provisions soared 284.71% in 2022 and tumbled 328.39% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Tax Provisions stood at $48150.0 in 2022, then sank by 48.17% to $24956.0 in 2023, then slumped by 328.39% to -$56996.0 in 2024, then jumped by 140.33% to $22989.0 in 2025, then slumped by 83.16% to $3871.0 in 2026.
• The last three Tax Provisions figures came in at $3871.0 (Q1 2026), $22989.0 (Q4 2025), and $5670.0 (Q3 2025), per Business Quant data.